Bank of America’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.24M Sell
274,164
-8,154
-3% -$36.8K ﹤0.01% 4323
2025
Q1
$1.25M Buy
282,318
+155,159
+122% +$687K ﹤0.01% 4228
2024
Q4
$996K Buy
127,159
+47,439
+60% +$371K ﹤0.01% 4251
2024
Q3
$1.05M Buy
79,720
+35,037
+78% +$461K ﹤0.01% 4259
2024
Q2
$540K Buy
44,683
+31,546
+240% +$381K ﹤0.01% 4536
2024
Q1
$214K Sell
13,137
-23,376
-64% -$380K ﹤0.01% 5022
2023
Q4
$249K Buy
36,513
+2,077
+6% +$14.2K ﹤0.01% 5057
2023
Q3
$188K Sell
34,436
-1,280
-4% -$6.98K ﹤0.01% 5070
2023
Q2
$243K Sell
35,716
-49,739
-58% -$338K ﹤0.01% 4895
2023
Q1
$428K Buy
85,455
+62,332
+270% +$312K ﹤0.01% 4719
2022
Q4
$113K Sell
23,123
-80,463
-78% -$393K ﹤0.01% 5432
2022
Q3
$1.49M Buy
103,586
+34,679
+50% +$500K ﹤0.01% 3892
2022
Q2
$1.04M Sell
68,907
-329,916
-83% -$4.99M ﹤0.01% 4220
2022
Q1
$4.74M Buy
398,823
+316,898
+387% +$3.76M ﹤0.01% 3205
2021
Q4
$1.33M Buy
81,925
+1,661
+2% +$26.9K ﹤0.01% 4284
2021
Q3
$2.29M Sell
80,264
-2,306
-3% -$65.8K ﹤0.01% 3692
2021
Q2
$2.79M Buy
82,570
+2
+0% +$68 ﹤0.01% 3490
2021
Q1
$2.5M Buy
82,568
+21,801
+36% +$659K ﹤0.01% 3566
2020
Q4
$3.01M Sell
60,767
-11,403
-16% -$565K ﹤0.01% 3095
2020
Q3
$2.77M Buy
72,170
+2,859
+4% +$110K ﹤0.01% 3006
2020
Q2
$2.99M Buy
69,311
+1,714
+3% +$74K ﹤0.01% 2946
2020
Q1
$1.76M Sell
67,597
-18,785
-22% -$490K ﹤0.01% 3169
2019
Q4
$2.7M Buy
86,382
+27,538
+47% +$860K ﹤0.01% 3248
2019
Q3
$1.53M Buy
58,844
+39,586
+206% +$1.03M ﹤0.01% 3610
2019
Q2
$441K Buy
19,258
+7,054
+58% +$162K ﹤0.01% 4439
2019
Q1
$321K Buy
12,204
+6,175
+102% +$162K ﹤0.01% 4569
2018
Q4
$122K Buy
6,029
+5,838
+3,057% +$118K ﹤0.01% 5073
2018
Q3
$5K Buy
+191
New +$5K ﹤0.01% 6088